Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
PAAB eFiles Tag and CEI Report 2024
-
Hello @Manufacturer and @Agency .
Please find uploaded the completed Tag report and CEI report for Q1 of 2024. We saw an 18.5% CEI completion rate in Q1. We hope to watch this number grow. Please let us know if you have any questions.
Have a great week.
